Evidence map›Paper›PMID 36938080›Full record

ArticleKidney international reports2023

Cardiovascular Risk Factor Burden and Association With CKD in Ghana and Nigeria.

Timothy O Olanrewaju, Charlotte Osafo, Yemi R Raji, Manmak Mamven, Samuel Ajayi, Titilayo O Ilori, Fatiu A Arogundade, Ifeoma I Ulasi, Rasheed Gbadegesin, Rulan S Parekh and 12 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 14 institutions in 6 countries.

Timothy O OlanrewajuDivision of Nephrology, Department of Medicine, University of Ilorin, Ilorin, Nigeria.
Charlotte OsafoUniversity of Ghana Medical School, College of Health Sciences, University of Ghana, Ghana.
Yemi R RajiDepartment of Medicine, University of Ibadan, Ibadan, Nigeria.
Manmak MamvenDepartment of Medicine, University of Abuja, Abuja, Nigeria.
Samuel AjayiDepartment of Medicine, University of Ibadan, Ibadan, Nigeria.
Titilayo O IloriSection of Nephrology, Department of Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
Fatiu A ArogundadeDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria.
Ifeoma I UlasiDepartment of Medicine, College of Health Sciences, University of Nigeria, Enugu, Nigeria.
Rasheed GbadegesinDepartment of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
Rulan S ParekhDepartment of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Bamidele TayoDepartment of Public Health Sciences, Loyola University Parkinson School of Health Sciences and Public Health, Maywood, Illinois, USA.
Adebowale A AdeyemoCenter for Research on Genomics and Global Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Olanrewaju T AdedoyinDepartment of Pediatrics, University of Ilorin, Ilorin, Nigeria.
Adindu A ChijiokeDivision of Nephrology, Department of Medicine, University of Ilorin, Ilorin, Nigeria.
Clement BewajiDepartment of Biochemistry, University of Ilorin, Ilorin, Nigeria.
Diederick E GrobbeeJulius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Peter J BlankestijnDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Kerstin Klipstein-GrobuschJulius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Babatunde L SalakoDepartment of Medicine, University of Ibadan, Ibadan, Nigeria.
Dwomoa AduUniversity of Ghana Medical School, College of Health Sciences, University of Ghana, Ghana.
Akinlolu O OjoUniversity of Kansas School of Medicine, Kansas City, Kansas, USA.
of H3Africa Kidney Disease Research Network Investigators
University of Ilorin · NGUniversity of Ibadan · NGUniversity of Ghana · GHUtrecht University · NLBoston University · USDuke Medical Center · USLoyola University Chicago · USNational Institutes of Health · USObafemi Awolowo University · NGUniversity of Abuja · NGUniversity of Kansas · USUniversity of Nigeria · NGUniversity of the Witwatersrand · ZAUniversity of Toronto · CA

Funding

H3Africa Kidney Disease Research Network- Collaborative CentersU54DK116913 · NIDDK · COLLEGE OF HEALTH SCIENCES, UNIVERSITY OF GHANA · PI ADU, DWOMOA, OJO, AKINLOLU OLUSEUN · 2017 to 2021
$4.1M
The H3Africa Kidney Disease Cohort StudyU01DK107131 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ADU, DWOMOA, OJO, AKINLOLU OLUSEUN · 2015 to 2019
$2.9M
The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 NephropathyK23DK119542 · NIDDK · BOSTON MEDICAL CENTER · PI ILORI, TITILAYO OMOLARA · 2020 to 2024
$928k
NIDDK NIH HHS K23 DK119542NIDDK NIH HHS U01 DK107131NIDDK NIH HHS U54 DK116913
6 · The paper itself

Abstract

Introduction: Cardiovascular disease is the leading cause of morbidity and mortality in patients with chronic kidney disease (CKD); however, the burden of cardiovascular risk factors in patients with CKD in Africa is not well characterized. We determined the prevalence of selected cardiovascular risk factors, and association with CKD in the Human Heredity for Health in Africa Kidney Disease Research Network study. Methods: We recruited patients with and without CKD in Ghana and Nigeria. CKD was defined as estimated glomerular filtration rate of <60 ml/min per 1.73 m Results: We enrolled 8396 participants (cases with CKD, 3956), with 56% females. The mean age (45.5 ± 15.1 years) did not differ between patients and control group. The prevalence of hypertension (59%), diabetes (20%), and elevated cholesterol (9.9%), was higher in CKD patients than in the control participants ( Conclusion: Cardiovascular risk factors are prevalent in middle-aged adult patients with CKD in Ghana and Nigeria, with higher proportions in Ghana than in Nigeria. Hypertension, elevated cholesterol, and underweight were independently associated with CKD.

Indexed as

Africacardiovascular risk factorscholesterolchronic kidney diseasediabeteshypertension

Identifiers

PMID36938080
PMCPMC10014339
OpenAlexW4310713961

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.